As CEO Departs, GenomeQuest Sets Sights on Growing Footprint in Whole-Genome-Analysis Market

Ron Ranauro resigned as CEO after eight years with the company. Richard Resnick, vice president of products and services, will serve as acting CEO while the firm searches for a permanent replacement.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories